0001181431-14-022661.txt : 20140623
0001181431-14-022661.hdr.sgml : 20140623
20140604162946
ACCESSION NUMBER: 0001181431-14-022661
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140602
FILED AS OF DATE: 20140604
DATE AS OF CHANGE: 20140604
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZOGENIX, INC.
CENTRAL INDEX KEY: 0001375151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205300780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
STREET 2: SUITE 650
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 259-1165
MAIL ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
STREET 2: SUITE 650
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: ZOGENIX INC
DATE OF NAME CHANGE: 20060911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shively Richard Scott
CENTRAL INDEX KEY: 0001438675
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34962
FILM NUMBER: 14891139
MAIL ADDRESS:
STREET 1: ALPHARMA PHARMACEUTICALS LLC
STREET 2: 440 ROUTE 22 EAST
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
4
1
rrd410340.xml
FORM 4_RSU DISPOSITION
X0306
4
2014-06-02
0
0001375151
ZOGENIX, INC.
ZGNX
0001438675
Shively Richard Scott
12400 HIGH BLUFF DRIVE, SUITE 650
SAN DIEGO
CA
92130
0
1
0
0
Chief Commercial Officer
Common Stock
2014-06-02
2014-06-02
4
S
0
17746
2.1023
D
360254
D
Common Stock
2014-06-03
2014-06-03
4
S
0
1464
2.0278
D
358790
D
Common Stock
2014-06-03
2014-06-03
4
S
0
19
2.00
D
358771
D
This sale of shares of common stock underlying vested restricted stock units was effected by the reporting person to cover the taxes payable upon the vesting of 46,000 restricted stock units on June 1, 2014.
Reflects the weighted average sale price of the shares sold. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Reflects the weighted average sale price of the shares sold. These shares were sold in multiple transactions at prices ranging from $2.03 to $2.27. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Thomas Doyle, Attorney-In-Fact
2014-06-04